Copyright
©2009 The WJG Press and Baishideng.
World J Gastroenterol. Feb 7, 2009; 15(5): 561-569
Published online Feb 7, 2009. doi: 10.3748/wjg.15.561
Published online Feb 7, 2009. doi: 10.3748/wjg.15.561
Figure 9 Effects of peptide at dose of 10 mg/L in TNF-α mRNA expression of AR42J by RT-PCR.
A: Images of agarose gel electrophoresis; 1: Control; 2: LPS; 3: Tat-NBD (WT); 4: NBD; 5: Tat-NBD (MT); 6: Tat; M: Marker; B: only Tat-NBD (WT) peptide decreased TNF-α mRNA expression. Control: Cells were incubated with buffer control (n = 3); LPS: Cells were stimulated by LPS for 2 h (n = 3); Tat-NBD (WT): Pretreatment with 10 mg/L of (n = 3); NBD: Pretreatment with 10 mg/L of NBD (n = 3); Tat-NBD (MT): Pretreatment with 10 mg/L of Tat-NBD (MT) (n = 3); Tat: Pretreatment with 100 mg/L of Tat (n = 3). bP < 0.01 vs LPS group. dP < 0.01 vs LPS group.
- Citation: Long YM, Chen K, Liu XJ, Xie WR, Wang H. Cell-permeable Tat-NBD peptide attenuates rat pancreatitis and acinus cell inflammation response. World J Gastroenterol 2009; 15(5): 561-569
- URL: https://www.wjgnet.com/1007-9327/full/v15/i5/561.htm
- DOI: https://dx.doi.org/10.3748/wjg.15.561